nach oben

Current Rheumatology Reports

Erschienen in:

01.11.2013 | OSTEOPOROSIS AND METABOLIC BONE DISEASE (KG SAAG, SECTION EDITOR)

Measuring Bone Quality

verfasst von: Elisa Torres-del-Pliego, Laia Vilaplana, Roberto Güerri-Fernández, Adolfo Diez-Pérez

Erschienen in: Current Rheumatology Reports | Ausgabe 11/2013

Einloggen, um Zugang zu erhalten

Abstract

Osteoporosis is defined as a reduction in bone mass and impairment of bone quality that lead to bone fragility and fracture risk. Bone quality includes a hierarchy of properties from macroscopic to nanoscale level. Several techniques have been developed in an attempt to measure these non-density properties. Densitometry, high-resolution images (radiography, CT scan), and MRI can measure the geometry and microarchitecture of bone. Tissue mineralization and composition can be assessed by use of microradiography, Fourier-transform infrared spectroscopy, or Raman microspectroscopy. Finite-element analysis is an image-based method that enables calculation of bone strength. More recently, microindentation has enabled direct estimation of bone material strength, measured in the cortical bone of the tibia. Most of these techniques are of limited use to clinics, although finite-element analysis and microindentation have high potential for clinical use and can enable more comprehensive and accurate evaluation of bone fragility and fracture susceptibility.

NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001 Feb 14;285(6):785–95.

NIA workshop on aging and bone quality. Bethesda, September 3-4, 1992, Proceedings. Calcif Tissue Int. 1993;53 Suppl 1:S1–180.

Cummings SR, Bates D, Black DM. Clinical use of bone densitometry: Scientific review. JAMA. 2002;288(15):1889–97.PubMedCrossRef

Maricic M, Gluck O. Densitometry in glucocorticoid-induced osteoporosis. J Clin Densitom. 2004;7(4):359–63.PubMedCrossRef

Watts NB, Geusens P, Barton IP, Felsenberg D. Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: Reduction in risk of nonvertebral fracture is not related to change in BMD. J Bone Miner Res. 2005;20(12):2097–104.PubMedCrossRef

Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. multiple outcomes of raloxifene evaluation (MORE) investigators. JAMA. 1999;282(7):637–45.PubMedCrossRef

Delmas PD, Seeman E. Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Bone. 2004;34(4):599–604.PubMedCrossRef

Chapurlat RD, Palermo L, Ramsay P, Cummings SR. Risk of fracture among women who lose bone density during treatment with alendronate. The fracture intervention trial. Osteoporos Int. 2005;16(7):842–8.PubMedCrossRef

Cummings SR, Bates D, Black DM. Clinical use of bone densitometry: Scientific review. JAMA. 2002;288(15):1889–97.PubMedCrossRef

10.

Black DM, Cummings SR, Karpf DB, et al. Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture intervention trial research group. Lancet. 1996;348(9041):1535–41.PubMedCrossRef

11.

Austin M, Yang YC, Vittinghoff E, et al. FREEDOM Trial. Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures. J Bone Miner Res. 2012;27(3):687–93.PubMedCrossRef

12.

Felsenberg D, Boonen S. The bone quality framework: Determinants of bone strength and their interrelationships, and implications for osteoporosis management. Clin Ther. 2005;27(1):1–11.PubMedCrossRef

13.

Bouxsein ML, Seeman E. Quantifying the material and structural determinants of bone strength. Best Pract Res Clin Rheumatol. 2009;23(6):741–53.PubMedCrossRef

14.

Ahlborg HG, Johnell O, Turner C, et al. Bone loss and bone size after menopause. N Engl J Med. 2003;349(4):327–34.PubMedCrossRef

15.

Kleerekoper M, Villanueva AR, Stanciu J, et al. The role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures. Calcif Tissue Int. 1985;37(6):594–7.PubMedCrossRef

16.

Slyfield CR, Tkachenko EV, Fischer SE, et al. Mechanical failure begins preferentially near resorption cavities in human vertebral cancellous bone under compression. Bone. 2012;50(6):1281–7.PubMedCrossRef

17.

Silva MJ, Gibson LJ. Modeling the mechanical behavior of vertebral trabecular bone: Effects of age-related changes in microstructure. Bone. 1997;21(2):191–9.PubMedCrossRef

18.

Weinstein RS, Hutson MS. Decreased trabecular width and increased trabecular spacing contribute to bone loss with aging. Bone. 1987;8(3):137–42.PubMedCrossRef

19.

Macdonald HM, Nishiyama KK, Kang J, et al. Age-related patterns of trabecular and cortical bone loss differ between sexes and skeletal sites: A population-based HR-pQCT study. J Bone Miner Res. 2011;26(1):50–62.PubMedCrossRef

20.

Bell KL, Loveridge N, Jordan GR, et al. A novel mechanism for induction of increased cortical porosity in cases of intracapsular hip fracture. Bone. 2000;27(2):297–304.PubMedCrossRef

21.

Ebacher V, Tang C, McKay H, et al. Strain redistribution and cracking behavior of human bone during bending. Bone. 2007;40(5):1265–75.PubMedCrossRef

22.

Koester KJ, Ager 3rd JW, Ritchie RO. The true toughness of human cortical bone measured with realistically short cracks. Nat Mater. 2008;7(8):672–7.PubMedCrossRef

23.

•• Zebaze RM, Ghasem-Zadeh A, Bohte A, et al. Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: A cross-sectional study. Lancet. 2010;375(9727):1729–36. Cortical bone is a key component of bone strength. The transition between cortical and trabecular compartments is difficult to establish due to the trabecularization of the inner side of the cortex. PubMedCrossRef

24.

Follet H, Boivin G, Rumelhart C, Meunier PJ. The degree of mineralization is a determinant of bone strength: A study on human calcanei. Bone. 2004;34(5):783–9.PubMedCrossRef

25.

Viguet-Carrin S, Farlay D, Bala Y, et al. An in vitro model to test the contribution of advanced glycation end products to bone biomechanical properties. Bone. 2008;42(1):139–49.PubMedCrossRef

26.

•• Saito M, Marumo K. Collagen cross-links as a determinant of bone quality: A possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int. 2010;21(2):195–214. Collagen maturity is relevant for the mechanical properties of bone. Increased cross-linking is associated with older, less mechanically efficient bone. PubMedCrossRef

27.

Boivin G, Bala Y, Doublier A, et al. The role of mineralization and organic matrix in the microhardness of bone tissue from controls and osteoporotic patients. Bone. 2008;43(3):532–8.PubMedCrossRef

28.

Currey JD, Brear K, Zioupos P. The effects of ageing and changes in mineral content in degrading the toughness of human femora. J Biomech. 1996;29(2):257–60.PubMedCrossRef

29.

Burr DB, Forwood MR, Fyhrie DP, et al. Bone microdamage and skeletal fragility in osteoporotic and stress fractures. J Bone Miner Res. 1997;12(1):6–15.PubMedCrossRef

30.

Burr DB. Targeted and nontargeted remodeling. Bone. 2002;30(1):2–4.PubMedCrossRef

31.

• Allen MR, Burr DB. Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: What we think we know and what we know that we don’t know. Bone. 2011;49(1):56–65. Excellent review on the potential deleterious effects of this group of drugs on bone mechanical properties. PubMedCrossRef

32.

Currey JD. The effects of drying and re-wetting on some mechanical properties of cortical bone. J Biomech. 1988;21(5):439–41.PubMedCrossRef

33.

Seeman E, Delmas PD. Bone quality–the material and structural basis of bone strength and fragility. N Engl J Med. 2006;354(21):2250–61.PubMedCrossRef

34.

Marcott C, Reeder RC, Paschalis EP, et al. Infrared microspectroscopic imaging of biomineralized tissues using a mercury-cadmium-telluride focal-plane array detector. Cell Mol Biol (Noisy-le-grand). 1998;44(1):109–15.

35.

Gourion-Arsiquaud S, West PA, Boskey AL. Fourier transform-infrared microspectroscopy and microscopic imaging. Methods Mol Biol. 2008;455:293–303.PubMedCrossRef

36.

Tjhia CK, Odvina CV, Rao DS, et al. Mechanical property and tissue mineral density differences among severely suppressed bone turnover (SSBT) patients, osteoporotic patients, and normal subjects. Bone. 2011;49(6):1279–89.PubMedCrossRef

37.

• Chappard D, Basle MF, Legrand E, Audran M. New laboratory tools in the assessment of bone quality. Osteoporos Int. 2011;22(8):2225–40. Comprehensive review of the available methods for the assessment of the BMD-independent elements of bone. PubMedCrossRef

38.

Burket J, Gourion-Arsiquaud S, Havill LM, et al. Microstructure and nanomechanical properties in osteons relate to tissue and animal age. J Biomech. 2011;44(2):277–84.PubMedCrossRef

39.

• Danielson ME, Beck TJ, Karlamangla AS, et al. A comparison of DXA and CT based methods for estimating the strength of the femoral neck in post-menopausal women. Osteoporos Int. 2013;24(4):1379–88. Study of the two methods commonly used for the calculations in finite element analyses. PubMedCrossRef

40.

Thevenot J, Hirvasniemi J, Finnila M, et al. Trabecular homogeneity index derived from plain radiograph to evaluate bone quality. J Bone Miner Res. 2013

41.

Diez-Perez A, Olmos JM, Nogues X, et al. Risk factors for prediction of inadequate response to antiresorptives. J Bone Miner Res. 2012;27(4):817–24.PubMedCrossRef

42.

Amin S, Kopperdhal DL, Melton 3rd LJ, et al. Association of hip strength estimates by finite-element analysis with fractures in women and men. J Bone Miner Res. 2011;26(7):1593–600.PubMedCrossRef

43.

Graeff C, Marin F, Petto H, et al. High resolution quantitative computed tomography-based assessment of trabecular microstructure and strength estimates by finite-element analysis of the spine, but not DXA, reflects vertebral fracture status in men with glucocorticoid-induced osteoporosis. Bone. 2013;52(2):568–77.PubMedCrossRef

44.

Srinivasan B, Kopperdahl DL, Amin S, et al. Relationship of femoral neck areal bone mineral density to volumetric bone mineral density, bone size, and femoral strength in men and women. Osteoporos Int. 2012;23(1):155–62.PubMedCrossRef

45.

•• Roux JP, Wegrzyn J, Arlot ME, et al. Contribution of trabecular and cortical components to biomechanical behavior of human vertebrae: An ex vivo study. J Bone Miner Res. 2010;25(2):356–61. Experimental research where the relative contribution of cortical and trabecular bone is studied. Fracture propensity is mainly driven by the cortical bone. PubMedCrossRef

46.

Zioupos P, Hansen U, Currey JD. Microcracking damage and the fracture process in relation to strain rate in human cortical bone tensile failure. J Biomech. 2008;41(14):2932–9.PubMedCrossRef

47.

Hvid I, Christensen P, Soondergaard J, Christensen PB, Larsen CG. Compressive strength of tibial cancellous bone. instron and osteopenetrometer measurements in an autopsy material. Acta Orthop Scand. 1983;54(6):819–25.PubMedCrossRef

48.

Imbeni V, Kruzic JJ, Marshall GW, et al. The dentin-enamel junction and the fracture of human teeth. Nat Mater. 2005;4(3):229–32.PubMedCrossRef

49.

Hansma P, Turner P, Drake B, et al. The bone diagnostic instrument II: Indentation distance increase. Rev Sci Instrum. 2008;79(6):064303.PubMedCrossRef

50.

Hansma P, Yu H, Schultz D, et al. The tissue diagnostic instrument. Rev Sci Instrum. 2009;80(5):054303.PubMedCrossRef

51.

•• Diez-Perez A, Guerri R, Nogues X, et al. Microindentation for in vivo measurement of bone tissue mechanical properties in humans. J Bone Miner Res. 2010;25(8):1877–85. First publication on microindentation with the validation and basic methodology. The technique discriminates between fracture and non-fracture cases. PubMedCrossRef

52.

•• Guerri-Fernandez RC, Nogues X, Quesada Gomez JM, et al. Microindentation for in vivo measurement of bone tissue material properties in atypical femoral fracture patients and controls. J Bone Miner Res. 2013;28(1):162–8. Second publication in humans analyzing a paradigm of bone quality deterioration, atypical femoral fractures. In spite of preserved bone density, mechanical properties of bone tissue are deeply deteriorated. PubMedCrossRef

53.

Dall’Ara E, Schmidt R, Zysset P. Microindentation can discriminate between damaged and intact human bone tissue. Bone. 2012;50(4):925–9.PubMedCrossRef

54.

•• Gallant MA, Brown DM, Organ JM, et al. Reference-point indentation correlates with bone toughness assessed using whole-bone traditional mechanical testing. Bone. 2013;53(1):301–5. Animal study of microindentation correlating the obtained variables of the technique with the classical mechanical tests in the laboratory. PubMedCrossRef

55.

Fantner GE, Hassenkam T, Kindt JH, et al. Sacrificial bonds and hidden length dissipate energy as mineralized fibrils separate during bone fracture. Nat Mater. 2005;4(8):612–6.PubMedCrossRef

Titel: Measuring Bone Quality
verfasst von: Elisa Torres-del-Pliego
Laia Vilaplana
Roberto Güerri-Fernández
Adolfo Diez-Pérez
Publikationsdatum: 01.11.2013
Verlag: Springer US
Erschienen in: Current Rheumatology Reports / Ausgabe 11/2013
Print ISSN: 1523-3774
Elektronische ISSN: 1534-6307
DOI: https://doi.org/10.1007/s11926-013-0373-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2013

Osteoporosis and Orthopedic Surgery: Effect of Bone Health on Total Joint Arthroplasty Outcome

Granuloma in ANCA-Associated Vasculitides: Another Reason to Distinguish Between Syndromes?

Outcome Assessments in Rheumatoid Arthritis

Mechanistic Insights from Animal Models of Psoriasis and Psoriatic Arthritis

Homeostatic Mechanisms in Articular Cartilage and Role of Inflammation in Osteoarthritis